 Glucosamine sulfate has recently attracted the attention of the scientific community and of patients, because two long-term 3 years clinical trials in comparison with placebo, showed that this is the first agent able to retard the progression of anatomic joint structure changes in knee osteoarthritis, besides controlling the progression of symptoms. 